Please use this identifier to cite or link to this item: http://nopr.niscair.res.in/handle/123456789/11614
Title: Development and validation of a robust QSAR model for prediction of carcinogenicity of drugs
Authors: Kar, Supratik
Roy, Kunal
Keywords: QSAR
Carcinogenicity
Drugs
Chemometric tools
Validation
Issue Date: Apr-2011
Publisher: NISCAIR-CSIR, India
Abstract: Carcinogenicity is one of the toxicological endpoints causing the highest concern. Also, the standard bioassays in rodents used to assess the carcinogenic potential of chemicals and drugs are extremely long, costly and require the sacrifice of large numbers of animals. For these reasons, we have attempted development of a global quantitative structure–activity relationship (QSAR) model using a data set of 1464 compounds (the Galvez data set available from http://www.uv.es/~galvez/tablevi.pdf), including many marketed drugs for their carcinogenesis potential. Though experimental toxicity testing using animal models is unavoidable for new drug candidates at an advanced stage of drug development, yet the developed global QSAR model can<i> in silico</i> predict the carcinogenicity of new drug compounds to provide a tool for initial screening of new drug candidate molecules with reduced number of animal testing, money and time. Considering large number of data points with diverse structural features used for model development (n<sub>training</sub> = 732) and model validation (n<sub>test</sub> = 732), the model developed in this study has an encouraging statistical quality (leave-one-out Q<sup>2</sup> = 0.731, R<sup>2</sup>pred = 0.716). Our developed model suggests that higher lipophilicity values and <span style="color: rgb(35, 31, 32);">conjugated ring systems, thioketo and nitro groups contribute positively towards drug carcinogenicity. On the contrary, <span style="color: rgb(35, 31, 32);">tertiary and secondary nitrogens, phenolic, enolic and carboxylic OH fragments and presence of three-membered rings reduce the carcinogenicity. Branching, size and shape are found to be crucial factors for drug-induced carcinogenicity. One may consider all these points to reduce carcinogenic potential of the molecules. </span></span>
Description: 111-122
URI: http://hdl.handle.net/123456789/11614
ISSN: 0975-0959 (Online); 0301-1208 (Print)
Appears in Collections:IJBB Vol.48(2) [April 2011]

Files in This Item:
File Description SizeFormat 
IJBB 48(2) 111-122.pdf267.36 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.